Not recruiting
Investigational
Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients
Investigational
- Substances:–
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Vor Biopharma Inc.
Back to SpainClinical trials in Barcelona – page 267
3 198 clinical trials in Barcelona, Spain across 23 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Barcelona at a glance
3 198
clinical trials
- Research sites23
Not recruiting
Diabetic retinal oedema
Not recruitingStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
Registered drugNo placebo
Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
Registered drugNo placebo
- Disease:Diabetic retinal oedema
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Eyebiotech Limited
Not recruiting
Non-small cell lung cancer
Not recruitingStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
Registered drug
Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
Registered drug
- Disease:Non-small cell lung cancer
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Clinipace Global Limited
Not recruiting
Narcolepsy
Not recruitingStudy on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1
Investigational
Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1
Investigational
- Disease:Narcolepsy
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:Alkermes Inc.
Not recruiting
Non-small cell lung cancer+1
Not recruitingStudy of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Registered drug
Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Registered drug
- Disease:Non-small cell lung cancerNon-small cell lung cancer metastatic
- Substances:–
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Sponsor:F. Hoffmann-La Roche AG
Status unknown
Chronic spontaneous urticaria
Status unknownStudy on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines
Registered drug
Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines
Registered drug
- Disease:Chronic spontaneous urticaria
- Substances:–
Countries:Spain
Spain- Participants:0–17 years
- Sponsor:Novartis Pharma AG
Other cities in Spain
The busiest research cities in the country
- Madrid3 342 trials · 24 research sites
- Valencia1 805 trials · 8 research sites
- Sevilla1 665 trials · 4 research sites
- Malaga1 064 trials · 4 research sites
- L'hospitalet De Llobregat991 trials · 4 research sites
- Badalona778 trials · 3 research sites
- Pamplona762 trials · 1 research site
- Santiago De Compostela691 trials · 3 research sites
Clinical research in Barcelona
What the registry says about research in the country
01 Neurodegenerative Research
Innovative studies focusing on Alzheimer's Disease and Frontotemporal Dementia, utilizing advanced brain imaging techniques to track disease progression and evaluate new therapeutic approaches.
- Cerebral tau aggregates assessment
- Amyloid deposition tracking
- Progressive supranuclear palsy research
Advanced neuroimaging studies using PET tracers to understand disease mechanisms.
02 Infectious Disease Prevention
Comprehensive vaccine trials targeting various infections including respiratory syncytial virus, Cytomegalovirus, and Herpes Zoster.
- RSV vaccine development for older adults
- CMV prevention studies
- COVID-19 booster research
Focus on developing effective immunization strategies for vulnerable populations.
03 Metabolic and Chronic Conditions
Research examining treatments for Type 1 Diabetes and obesity, alongside studies in bladder cancer and urinary tract infections.
- Diabetes management therapies
- Cancer immunotherapy trials
- UTI vaccine development
Innovative approaches to chronic disease management and prevention.